Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare
Eloxx Pharmaceuticals, Inc. Income Statement 2010–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2010 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 0 | 6.4M | 0 | 182,229 | 7,819 | 200,000 | 140,000 |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | -6.4M | -2.5M | -17.3M | -9.1M | -4.7M | -5.4M | -4.8M |
| EBITDA | — | — | — | -8.8M | -4.4M | -5.2M | -4.7M |
| Net Income | -6.0M | -3.1M | -17.1M | -9.2M | -6.1M | -5.1M | -13.4M |
| Per Share Data | |||||||
| EPS (diluted) | $-0.49 | $-0.84 | $-6.63 | — | — | — | — |
| Shares Outstanding (dil.) | 12M | 4M | 3M | 14M | 2M | 94M | — |
Eloxx Pharmaceuticals, Inc. Income Statement — FAQ
Eloxx Pharmaceuticals, Inc. (ELOX) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELOX's income statement history?
The chart and table above show Eloxx Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.